Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00424489
Recruitment Status : Terminated (No participants enrolled for more than two years. No plan to continue study.)
First Posted : January 19, 2007
Last Update Posted : July 12, 2016
Information provided by (Responsible Party):
Richard Burt, MD, Northwestern University

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Primary Completion Date : June 2016
  Study Completion Date : June 2016

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 June 20, 2017 November 2, 2017
2 November 3, 2017